The groundbreaking therapy of this peptide represents a major breakthrough in the management of the condition. Unlike existing drugs, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide785823.wizzardsblog.com/41939453/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment